CEACAM5 and gastric cancer: Compared to OA patients, AYA patients with GC tend to have fewer clinical manifestations, a higher prevalence of females, poorer differentiation, normal CEA levels, a lower proportion of tumors located in the upper third of the stomach, a greater likelihood of perineural invasion, and a higher rate of receiving adjuvant chemotherapy.